- Diagnostic Différentiel
Drug Information for Levonorgestrel Tablets, 0.75 mg (Rebel Distributors Corp.): HOW SUPPLIED
- CLINICAL PHARMACOLOGY
- INDICATIONS AND USAGE
- Clinical Studies
- ADVERSE REACTIONS
- DRUG ABUSE AND DEPENDENCE
- DOSAGE AND ADMINISTRATION
- HOW SUPPLIED
- Liens externes liés à Levonorgestrel Tablets, 0.75 mg (Rebel Distributors Corp.)
Levonorgestrel Tablets, 0.75 mg are available for a single course of treatment in PVC/aluminum foil blister packages of two tablets each. Each tablet is peach, round, bevel edged, and flat faced embossed with “475” on one side and “WATSON” on the other side.
Unit-of-use NDC 0591-0475-36
Store levonorgestrel tablets at controlled room temperature, 20° to 25°C (68° to 77°F); excursions permitted between 15° to 30°C (59° to 86°F) [See USP].
*The following are registered trademarks of their respective manufacturers: Reality® is manufactured by Female Health Company and a registered trademark of Meijer, Inc.; Depo-Provera® is manufactured by and a registered trademark of Pharmacia and Upjohn; Norplant® is manufactured by and a registered trademark of Population Council; Ovral®, Alesse®, Triphasil® and Lo Ovral®/Wyeth Pharmaceuticals, Inc.; Nordette®/Duramed Pharmaceuticals, Inc.; Levlen® and Tri- Levlen®/Bayer Healthcare.
Watson Laboratories, Inc.Corona, CA 92880 USAPhone: 1-800-272-552514816-3
Repackaged by:Rebel Distributors Corp.Thousand Oaks, CA 91320
- Drug Information Provided by National Library of Medicine (NLM).